Furthermore, we observed that altered GRIM-19 expression not only regulated p53 and HIF-1α activities, but also altered aerobic glycolysis, cell proliferation and tumorigenic capacity of HNSCC cells. This evidence concerns the gene NDUFA13 and head and neck squamous cell carcinoma.